DexCom, Inc. (DXCM)
After hours:
| Previous close | 106.65 |
| Open | 106.36 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 105.04 - 107.74 |
| 52-week range | 66.89 - 134.76 |
| Volume | |
| Avg. volume | 2,596,424 |
| Market cap | 41.221B |
| Beta (5Y monthly) | 1.16 |
| PE ratio (TTM) | 237.16 |
| EPS (TTM) | 0.45 |
| Earnings date | 09 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 129.68 |
- Zacks
DexCom (DXCM) Gains But Lags Market: What You Should Know
DexCom (DXCM) closed the most recent trading day at $106.72, moving +0.07% from the previous trading session.
- Zacks
Masimo's (MASI) Patient Monitoring Devices Favored by New Study
Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.
- Business Wire
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
SAN DIEGO, January 24, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2022 financial results after market close on Thursday, February 9, 2023. Management will hold a conference call to review the company's fourth quarter and full year 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website a
